{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:16:18Z","timestamp":1777806978365,"version":"3.51.4"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["EXC 2189"],"award-info":[{"award-number":["EXC 2189"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["EXC294"],"award-info":[{"award-number":["EXC294"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.imlet.2025.107126","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:57:17Z","timestamp":1767167837000},"page":"107126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["LCK at the crossroad of immunodeficiency and autoimmunity: Mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-8406","authenticated-orcid":false,"given":"Nadine M.","family":"Woessner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baerbel","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-5538","authenticated-orcid":false,"given":"Susana","family":"Minguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107126_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-023-01614-4","article-title":"Combined immunodeficiency caused by a novel nonsense mutation in LCK","volume":"44","author":"Keller","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0002","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230927","article-title":"A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation","volume":"221","author":"Lui","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0003","first-page":"130","article-title":"Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency","author":"Hauck","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-023-01602-8","article-title":"A novel biallelic LCK variant resulting in profound T-Cell immune deficiency and review of the literature","volume":"44","author":"Lanz","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/bjd.14679","article-title":"Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma","volume":"175","author":"Li","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.imlet.2025.107126_bib0006","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1080\/14756366.2021.1937143","article-title":"New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011\u20132021) focussing on structure\u2013activity relationship (SAR) and docking insights","volume":"36","author":"Elkamhawy","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0007","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1038\/sj.onc.1208081","article-title":"Structure and regulation of Src family kinases","volume":"23","author":"Boggon","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.imlet.2025.107126_bib0008","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/bj3030749","article-title":"Palmitoylation of multiple Src-family kinases at N-terminal motif a homologous","volume":"753","author":"Koegl","year":"1994","journal-title":"Biochem J."},{"key":"10.1016\/j.imlet.2025.107126_bib0009","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1093\/emboj\/16.16.4983","article-title":"S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes","volume":"16","author":"Kabouridis","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.imlet.2025.107126_bib0010","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1128\/MCB.15.12.6914","article-title":"Palmitoylation of either Cys-3 or Cys-5 is required for the biological activity of the Lck tyrosine protein kinase","volume":"15","author":"Yurchak","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0011","first-page":"630","article-title":"The unique domain forms a fuzzy intramolecular complex in src family kinases","volume":"25","author":"Maffei","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107126_bib0012","first-page":"1","article-title":"Structure determination of human Lck unique and SH3 domains by nuclear magnetic resonance spectroscopy","volume":"7","author":"Briese","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0013","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1073\/pnas.85.14.5190","article-title":"The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes","volume":"85","author":"Rudd","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2025.107126_bib0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(88)90053-0","article-title":"The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrasine-protein kinase p56lck","volume":"55","author":"Veillette","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107126_bib0015","first-page":"1853","article-title":"Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56 lck tyrosine protein kinase","volume":"10","author":"Shaw","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0016","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0092-8674(90)90090-2","article-title":"Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs","volume":"60","author":"Turner","year":"1990","journal-title":"Cell"},{"issue":"80-","key":"10.1016\/j.imlet.2025.107126_bib0017","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1126\/science.1085643","article-title":"A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8","volume":"301","author":"Kim","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.imlet.2025.107126_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12026-020-09148-2","article-title":"The role of competing mechanisms on Lck regulation","volume":"68","author":"Bozso","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2025.107126_bib0019","doi-asserted-by":"crossref","first-page":"14666","DOI":"10.1074\/jbc.M111911200","article-title":"Characterization of the in vivo sites of serine phosphorylation on Lck identifying serine 59 as a site of mitotic phosphorylation","volume":"277","author":"Kesavan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0020","author":"Yu"},{"key":"10.1016\/j.imlet.2025.107126_bib0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/359851a0","article-title":"Crystal structure of a Src-homology 3 (SH3) domain","volume":"359","author":"Musacchio","year":"1992","journal-title":"Lett. to Nat."},{"key":"10.1016\/j.imlet.2025.107126_bib0022","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-020-0732-3","article-title":"Noncanonical binding of Lck to CD3\u03b5 promotes TCR signaling and CAR function","volume":"21","author":"Hartl","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0023","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/385595a0","article-title":"Three-dimensional structure of the tyrosine kinase c-Src","volume":"385","author":"Xu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0024","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0092-8674(93)90405-F","article-title":"Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain : crystal structures of the complexed and peptide-free forms","volume":"72","author":"Waksman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107126_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/362087a0","article-title":"Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck","volume":"362","author":"Eck","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0026","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0959-440X(97)80146-7","article-title":"Structures of Src-family tyrosine kinases","volume":"7","author":"Sicheri","year":"1997","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0027","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/384484a0","article-title":"Structural basis for activation of human lymphocyte kinase Lek upon tyrosine phosphorylation","volume":"384","author":"Yamaguchi","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0028","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.immuni.2010.05.011","article-title":"Article constitutively active lck kinase in T cells drives antigen receptor signal transduction","volume":"32","author":"Nika","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0029","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nsmb.2762","article-title":"In vitro membrane reconstitution of the T-cell receptor proximal signaling network","volume":"21","author":"Hui","year":"2014","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1016\/j.imlet.2025.107126_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.aaf4736","article-title":"De novo phosphorylation and conformational opening of the tyrosine kinase Lck act in concert to initiate T cell receptor signaling","volume":"10","author":"Philipsen","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.imlet.2025.107126_bib0031","first-page":"971","article-title":"Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains","volume":"7","author":"Veillette","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.imlet.2025.107126_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2001893","article-title":"Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling","volume":"4","author":"Schoenborn","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.imlet.2025.107126_bib0033","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/365156a0","article-title":"Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk","volume":"365","author":"Chow","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0034","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.str.2024.09.010","article-title":"Predicting protein interactions of the kinase Lck critical to T cell modulation","volume":"32","author":"Gao","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.imlet.2025.107126_bib0035","doi-asserted-by":"crossref","first-page":"24880","DOI":"10.1074\/jbc.271.40.24880","article-title":"Regulation of the Lck SH2 domain by tyrosine phosphorylation","volume":"271","author":"Couture","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0036","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.molcel.2017.06.024","article-title":"A phosphosite within the SH2 domain of Lck regulates its activation by CD45","volume":"67","author":"Courtney","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.imlet.2025.107126_bib0037","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-00673-z","article-title":"Tyrosine 192 within the SH2 domain of the Src\u2011protein tyrosine kinase \u00ad regulates T\u2011cell activation independently of Lck\/CD45 interactions","volume":"18","author":"K\u00e4stle","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.imlet.2025.107126_bib0038","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.M101219200","article-title":"Specific dephosphorylation of the Lck tyrosine protein kinase at Tyr-394 by the SHP-1 protein-tyrosine phosphatase","volume":"276","author":"Chiang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0039","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.M600498200","article-title":"Identification of substrates of human protein-tyrosine phosphatase PTPN22","volume":"281","author":"Wu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2007.07.015","article-title":"The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses","volume":"27","author":"McNeill","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0041","doi-asserted-by":"crossref","first-page":"22101","DOI":"10.1074\/jbc.M110.196733","article-title":"Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148","volume":"286","author":"Stepanek","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0042","doi-asserted-by":"crossref","first-page":"28514","DOI":"10.1074\/jbc.M114.574319","article-title":"Phosphatase CD45 both positively and negatively regulates T cell receptor phosphorylation in reconstituted membrane protein clusters","volume":"289","author":"Furlan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45 : a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20143500","article-title":"Beyond TCR signaling: emerging functions of Lck in cancer and immunotherapy","volume":"20","author":"Bommhardt","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107126_bib0045","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1128\/MCB.16.9.4996","article-title":"Mutational analysis of Lck in CD45-Negative T Cells: dominant role of Tyrosine 394 phosphorylation in kinase activity","volume":"16","author":"D\u2019Oro","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0046","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ni895","article-title":"TCR ligand discrimination is enforced by competing ERK positive and SHP-I negative feedback pathways","volume":"4","author":"\u0160tefanov\u00e1","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0047","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.immuni.2010.03.006","article-title":"CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development","volume":"32","author":"Zikherman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.2003607","article-title":"T cell activation results in conformational changes in the Src family kinase Lck to induce its activation","volume":"6","author":"Stirnweiss","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.imlet.2025.107126_bib0049","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.271.13.7465","article-title":"Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394","volume":"271","author":"Bougeret","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0050","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.4049\/jimmunol.162.4.1879","article-title":"Cutting Edge: The CD45 Tyrosine Phosphatase Is an Inhibitor of Lck Activity in Thymocytes","volume":"162","author":"D`Oro","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0051","first-page":"3","article-title":"Lck, membrane microdomains, and TCR triggering machinery : defining the new rules of engagement","author":"Filipp","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0052","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1073\/pnas.90.11.5176","article-title":"Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck","volume":"90","author":"Winkler","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2025.107126_bib0053","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3640","article-title":"Recruitment of calcineurin to the T cell receptor positively regulates T cell activation","volume":"18","author":"Dutta","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0054","doi-asserted-by":"crossref","first-page":"23275","DOI":"10.1016\/S0021-9258(19)49459-3","article-title":"Phosphorylation of serine 59 of p56lck in activated T cells","volume":"268","author":"Watts","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-11-4","article-title":"TCR activation kinetics and feedback regulation in primary human T cells","volume":"11","author":"Poltorak","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.imlet.2025.107126_bib0056","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/S0021-9258(18)53403-7","article-title":"Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events","volume":"268","author":"Secrist","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0057","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.4049\/jimmunol.0802639","article-title":"Genetically encoded f\u00f6rster resonance energy transfer sensors for the conformation of the Src family kinase lck","volume":"182","author":"Paster","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0058","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau2001","article-title":"Biophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor","volume":"5","author":"Wan","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.imlet.2025.107126_bib0059","series-title":"Proc. Natl. Acad. Sci","article-title":"Lck bound to coreceptor is less active than free Lck","author":"Wei","year":"2020"},{"key":"10.1016\/j.imlet.2025.107126_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/icb.2014.100","article-title":"The pool of preactivated Lck in the initiation of T-cell signaling: a critical re-evaluation of the Lck standby model","volume":"93","author":"Ballek","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0061","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2020.07.018","article-title":"Multiple signaling roles of CD3\u03b5 and its application in CAR-T cell therapy","volume":"182","author":"Wu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107126_bib0062","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/cells10040834","article-title":"Cooperative interaction of Nck and Lck orchestrates optimal TCR sgnaling","volume":"10","author":"Hartl","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.imlet.2025.107126_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2024.1392933","article-title":"Phospho-mimetic CD3 e variants prevent TCR and CAR signaling","volume":"15","author":"Woessner","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.imlet.2025.107126_bib0064","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bj.2022.01.013","article-title":"Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling","volume":"45","author":"Latour","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.imlet.2025.107126_bib0065","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaci.2016.05.036","article-title":"Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency","volume":"139","author":"Bacchelli","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0066","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41435-023-00215-w","article-title":"Clinical, immunological and molecular findings of 8 patients with typical and atypical severe combined immunodeficiency: identification of 7 novel mutations by whole exome sequencing","volume":"24","author":"Alizadeh","year":"2023","journal-title":"Genes Immun"},{"key":"10.1016\/j.imlet.2025.107126_bib0067","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2013.01.020","article-title":"Partial defects of T-cell development associated with poor T-cell function","volume":"131","author":"Notarangelo","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0068","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.molmed.2015.04.002","article-title":"Recent advances in understanding the pathophysiology of primary T cell immunodeficiencies","volume":"21","author":"Fischer","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0069","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/357161a0","article-title":"Profound block in thymocyte development in mice lacking p56lck","volume":"357","author":"Molina","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1074-7613(00)80499-9","article-title":"\u03b1\u03b2 T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases","volume":"5","author":"Van Oers","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0071","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/nyas.12849","article-title":"Severe combined immunodeficiency-An update","volume":"1356","author":"Cirillo","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2025.107126_bib0072","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.biopha.2018.10.002","article-title":"Exploration of the therapeutic aspects of Lck: a kinase target in inflammatory mediated pathological conditions","volume":"108","author":"Singh","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2025.107126_bib0073","first-page":"1213","article-title":"Lck inhibitors as a therapeutic approach to autoimmune diseases and transplant rejection","volume":"2","author":"Kamens","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.imlet.2025.107126_bib0074","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.2337\/diabetes.51.11.3326","article-title":"No association between lck gene polymorphisms and protein level in Type 1 diabetes","volume":"51","author":"Nervi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2025.107126_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41390-019-0436-2","article-title":"LCK rs10914542-G allele associates with type 1 diabetes in children via T cell hyporesponsiveness","volume":"86","author":"Zhu","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.imlet.2025.107126_bib0076","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2019-215533","article-title":"Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome highlight T cell-initiated autoimmunity","volume":"79","author":"Wang","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107126_bib0077","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107126_bib0078","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1006\/clim.2002.5298","article-title":"During the early prediabetic period in NOD mice, the pathogenic CD8+ T-cell population comprises multiple antigenic specificities","volume":"105","author":"DiLorenzo","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0079","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imlet.2025.107126_bib0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tem.2014.10.004","article-title":"Protein tyrosine phosphatases: molecular switches in metabolism and diabetes","volume":"26","author":"Gurzov","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.imlet.2025.107126_bib0081","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.2337\/db15-0638","article-title":"\u03b2ig-h3 represses T-cell activation in type 1 diabetes","volume":"64","author":"Patry","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2025.107126_bib0082","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.2337\/db12-1010","article-title":"Inhibition of src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice","volume":"62","author":"Taniguchi","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2025.107126_bib0083","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2015.09.008","article-title":"Inhibition of c-Src\/p38 MAPK pathway ameliorates renal tubular epithelial cells apoptosis in db\/db mice","volume":"417","author":"Wu","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.imlet.2025.107126_bib0084","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 antibody, teplizumab, in relatives at risk for Type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0085","first-page":"1","article-title":"Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity","author":"Du","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2025.107126_bib0086","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJM199912093412407","article-title":"Inflammatory skin diseases, T cells, and immune surveillance","volume":"341","author":"Robert","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0087","first-page":"9","article-title":"The Th17 axis in psoriatic disease: Pathogenetic and therapeutic implications, Autoimmun","volume":"5","author":"Marinoni","year":"2014","journal-title":"Highlights"},{"key":"10.1016\/j.imlet.2025.107126_bib0088","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","article-title":"The IL-23\/IL-17 axis in psoriatic arthritis","volume":"13","author":"Suzuki","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2025.107126_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106369","article-title":"Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17\/Treg immune responses and reduction of oxidative stress","volume":"83","author":"Nadeem","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2025.107126_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sji.12742","article-title":"Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice","volume":"89","author":"Kim","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0091","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2025.107126_bib0092","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2025.107126_bib0093","first-page":"369","article-title":"Psoriasis","volume":"11","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104531","article-title":"Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model","volume":"376","author":"Al-Harbi","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2140","article-title":"First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases","volume":"8","author":"Borroto","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0096","series-title":"Resetting the immune system to restore healthy responses","author":"Artax BioPharma","year":"2025"},{"key":"10.1016\/j.imlet.2025.107126_bib0097","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/316744a0","article-title":"T cells with receptors for lgD","volume":"316","author":"Coico","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2025.107126_bib0098","article-title":"The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2025.107126_bib0099","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41401-021-00665-w","article-title":"An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis","volume":"43","author":"xi Hu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.imlet.2025.107126_bib0100","first-page":"1","article-title":"Regulation of T cell activities in rheumatoid arthritis by the novel fusion protein IgD-Fc-Ig","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1124\/jpet.114.218164","article-title":"The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-Cell cancer","volume":"351","author":"Coffey","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imlet.2025.107126_bib0102","article-title":"STAT3 phosphorylation in the rheumatoid arthritis immunological synapse","author":"Kotzer","year":"2025","journal-title":"J. Autoimmun"},{"issue":"80-","key":"10.1016\/j.imlet.2025.107126_bib0103","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","article-title":"Enhanced DNA-binding activity of a stat3-related protein in cells transformed by the Src oncoprotein","volume":"269","author":"Yu","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.imlet.2025.107126_bib0104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2025.107126_bib0105","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13012","article-title":"Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients","volume":"48","author":"Chen","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107126_bib0106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00391","article-title":"Altered Th17\/treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome","volume":"10","author":"\u00c1lvarez-Rodr\u00edguez","year":"2019","journal-title":"Front. Immunol"},{"key":"10.1016\/j.imlet.2025.107126_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103213","article-title":"Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus","volume":"22","author":"Wang","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2025.107126_bib0108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08916939908995380","article-title":"P56(Lck) activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus","volume":"29","author":"Matache","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08916930108994123","article-title":"Dysregulation of p56lck kinase in patients with Systemic Lupus Erythematosus","volume":"34","author":"Matache","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.10978","article-title":"Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus","volume":"48","author":"Jury","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2025.107126_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.aat5401","article-title":"GLK-IKK signaling induces dimerization and translocation of the AhR-RORt complex in IL-17A induction and autoimmune disease","volume":"4","author":"Chuang","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.imlet.2025.107126_bib0112","first-page":"16","article-title":"Lck function and modulation: immune cytotoxic response and tumor treatment more than a simple event","author":"De Sanctis","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.imlet.2025.107126_bib0113","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI0215786","article-title":"JAK-STAT signaling in asthma","volume":"109","author":"Pernis","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107126_bib0114","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.0901282","article-title":"Lck mediates Th2 differentiation through effects on T-bet and GATA-3","volume":"184","author":"Kemp","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2010.06.025","article-title":"The role of the T cell in asthma","volume":"126","author":"Robinson","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0116","first-page":"15146","article-title":"The effect of siRNA-mediated lymphocyte-specific protein tyrosine kinase (Lck) inhibition on pulmonary inflammation in a mouse model of asthma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0117","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12090793","article-title":"Blockade of tyrosine kinase, LCK leads to reduction in airway inflammation through regulation of pulmonary Th2\/Treg balance and oxidative stress in cockroach extract-induced mouse model of allergic asthma","volume":"12","author":"Alqarni","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.imlet.2025.107126_bib0118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0119","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08916930601183522","article-title":"The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting","volume":"40","author":"Correale","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2025.107126_bib0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.imlet.2025.107126_bib0121","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.553616","article-title":"Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis","volume":"11","author":"Ziliotto","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.imlet.2025.107126_bib0122","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001069","article-title":"Melanoma cell adhesion molecule expressing helper T Cells in CNS inflammatory demyelinating diseases","volume":"8","author":"Ikeguchi","year":"2021","journal-title":"Neurol. Neuroimmunol. NeuroInflammation"},{"key":"10.1016\/j.imlet.2025.107126_bib0123","doi-asserted-by":"crossref","DOI":"10.1002\/ana.410360716","article-title":"The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion","volume":"36","author":"Raine","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imlet.2025.107126_bib0124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.imlet.2025.107126_bib0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2025.107126_bib0127","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-\u03b2","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imlet.2025.107126_bib0128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2008.08.030","article-title":"Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells","volume":"130","author":"Montes","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0129","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI29251","article-title":"Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis","volume":"116","author":"Astier","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107126_bib0130","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/eji.200737271","article-title":"IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis","volume":"38","author":"Martinez-Forero","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2025.107126_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17091398","article-title":"Regulatory cell populations in relapsing-remitting multiple sclerosis (RRMS) patients: effect of disease activity and treatment regimens","volume":"17","author":"Rodi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107126_bib0133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88448-5","article-title":"Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells","volume":"11","author":"Verma","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107126_bib0134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107126_bib0135","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1073\/pnas.89.10.4588","article-title":"\u03b3\u03b4 T-cell receptor repertoire in acute multiple sclerosis lesions","volume":"89","author":"Wucherpfennig","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2025.107126_bib0136","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1073\/pnas.90.3.923","article-title":"Clonal expansions of activated \u03b3\/\u03b4 T cells in recent-onset multiple sclerosis","volume":"90","author":"Shimonkevitz","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2025.107126_bib0137","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1600-6143.2009.02639.x","article-title":"Recent developments in kidney transplantation - a critical assessment","volume":"9","author":"Womer","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imlet.2025.107126_bib0138","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.1830251125","article-title":"Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck","volume":"25","author":"Wen","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.imlet.2025.107126_bib0139","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0041-1345(02)02909-3","article-title":"A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection","volume":"34","author":"Waegell","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.imlet.2025.107126_bib0140","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.bmcl.2004.02.101","article-title":"A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection","volume":"14","author":"Borhani","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.imlet.2025.107126_bib0141","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.105.089169","article-title":"A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection","volume":"315","author":"Stachlewitz","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.imlet.2025.107126_bib0142","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bmcl.2005.09.039","article-title":"Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection","volume":"16","author":"Burchat","year":"2006","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.imlet.2025.107126_bib0143","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149934","article-title":"Calcineurin inhibitors target Lck activation in graft-versus-host disease","volume":"131","author":"Carter","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2025.107126_bib0144","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.bbmt.2018.07.013","article-title":"Repurposing nilotinib for cytomegalovirus infection prophylaxis after allogeneic hematopoietic stem cell transplantation: a single-arm, Phase II trial","volume":"24","author":"Lin","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.imlet.2025.107126_bib0145","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1038\/s41409-020-0902-9","article-title":"Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)","volume":"55","author":"Olivieri","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imlet.2025.107126_bib0146","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41409-022-01898-x","article-title":"Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and\/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone","volume":"58","author":"Srour","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imlet.2025.107126_bib0147","doi-asserted-by":"crossref","first-page":"eabp9675","DOI":"10.1126\/scitranslmed.abp9675","article-title":"Human \u03b2-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling","volume":"14","author":"R\u00fcckert","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2025.107126_bib0148","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.imlet.2025.107126_bib0149","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.imlet.2025.107126_bib0150","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2025.107126_bib0151","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000220649.10013.5c","article-title":"T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome","volume":"98","author":"Pryshchep","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.imlet.2025.107126_bib0152","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1161\/01.ATV.17.11.3278","article-title":"Identification of the src family kinases, Lck and Fgr in platelets: Their tyrosine phosphorylation status and subcellular distribution compared with other Src family members, Arterioscler","volume":"17","author":"Pestina","year":"1997","journal-title":"Thromb. Vasc. Biol"},{"key":"10.1016\/j.imlet.2025.107126_bib0153","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.4049\/jimmunol.1502710","article-title":"Lck inhibits heat shock protein 65\u2013mediated reverse cholesterol transport in T cells","volume":"197","author":"Luo","year":"2016","journal-title":"J. Immunol"},{"key":"10.1016\/j.imlet.2025.107126_bib0154","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imlet.2025.107126_bib0155","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1074\/jbc.271.2.695","article-title":"Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck- and FynT-dependent T cell activation","volume":"271","author":"Hanke","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.imlet.2025.107126_bib0156","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0969-2126(99)80086-0","article-title":"Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors","volume":"7","author":"Zhu","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.imlet.2025.107126_bib0157","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/cb300172e","article-title":"Development of a highly selective c-Src kinase inhibitor","volume":"7","author":"Brandvold","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.imlet.2025.107126_bib0158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-681","article-title":"A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells","volume":"14","author":"Duan","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.imlet.2025.107126_bib0159","doi-asserted-by":"crossref","unstructured":"K. Kagawa, S. Sato, K. Koyama, T. Imakura, K. Murakami, Y. Yamashita, N. Naito, H. Ogawa, H. Kawano, Y.N. Id, The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF- \u03b2 production in regulatory T-cells, (2022) 1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0275987.","DOI":"10.1371\/journal.pone.0275987"},{"key":"10.1016\/j.imlet.2025.107126_bib0160","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.imlet.2025.107126_bib0161","article-title":"Controlling TCR and CAR activation by targeting LCK recruitment with a first-in-class small-molecule inhibitor","author":"Woessner","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.imlet.2025.107126_bib0162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01862","article-title":"Tyrosine kinases in autoimmune and inflammatory skin diseases","volume":"10","author":"Szilveszter","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825001592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:48:15Z","timestamp":1777495695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825001592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":162,"alternative-id":["S0165247825001592"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107126","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LCK at the crossroad of immunodeficiency and autoimmunity: Mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107126"}}